ArticlesFrequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
References (29)
- et al.
Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
Lancet
(1992) - et al.
Genetic diagnosis of lymph-node metastasis in colorectal cancer
Lancet
(1995) - et al.
Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure
Ann Thorac Surg
(1981) - et al.
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation
Cell
(1991) - et al.
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
Lancet
(1994) - et al.
Cancer of the lung
- et al.
Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies
Proc Natl Acad Sci USA
(1987) - et al.
Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer
Cancer Res
(1993) - et al.
Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
J Hematother
(1994) - et al.
Monoclonal cytokeratin antibodies that distinguish simple from stratified squamous epithelia
EMBO J
(1982)
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP-complexes)
J Histochem Cytochem
Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small cell lung cancer
J Clin Oncol
Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues
Cancer Res
Ber-EP4: new monoclonal antibody which distinguishes epithelial from mesothelia
J Clin Pathol
Cited by (383)
Disseminated tumor cells in bone marrow of cancer patients: Biology and clinical relevance
2021, Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to BedsideBlood tests for early detection of lung cancer: challenges and promises
2020, The Lancet Respiratory MedicineExternal Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non–Small Cell Lung Cancer Patients With N3 Disease
2017, Clinical Lung CancerCitation Excerpt :The same factors were found to be independent prognosticators for DSS (Table 4). The majority of patients with NSCLC present with advanced-stage or metastatic disease, with a significant portion developing distant relapse.9,10 Historically, the 5-year survival rate for those with stage IIIB cancers has been dismal at approximately 5%, and for those with distant metastases even lower.11
Cancer stem cells: The root of tumor recurrence and metastases
2017, Seminars in Cancer BiologyCitation Excerpt :The steady state that regulates dormancy might be disturbed by both changes in DTC (for example, additional mutations or epigenetic modifications in genes controlling cell proliferation and apoptosis) and the surrounding microenvironment [123]. Cancer cells in patients with breast, lung and prostate cancer disseminate early into the bone marrow and pose a risk for subsequent relapse [132–134]. Despite the common belief that tumor cell “shedding” is a passive random process, there is evidence for an expression signature related to the presence of CTC/DTC [135,136].
Chapter 115A - Liver transplantation for hepatocellular carcinoma
2016, Blumgart's Surgery of the Liver, Biliary Tract and Pancreas: Sixth Edition